WallStreetZenWallStreetZen

NASDAQ: KALV
Kalvista Pharmaceuticals Inc Stock Ownership - Who owns Kalvista Pharmaceuticals?

Insider buying vs selling

Have Kalvista Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Benjamin L. PalleikoCHIEF EXECUTIVE OFFICER2024-06-077,465$11.53
$86.07kSell
Edward P. FeenerCHIEF SCIENTIFIC OFFICER2024-05-208,088$11.76
$95.15kSell
Benjamin L. PalleikoCHIEF EXECUTIVE OFFICER2024-05-2021,959$11.76
$258.33kSell
Paul K. AudhyaCHIEF MEDICAL OFFICER2024-05-2013,175$11.76
$154.99kSell
Christopher YeaCHIEF DEVELOPMENT OFFICER2024-05-2011,610$11.76
$136.58kSell
Edward P. FeenerCHIEF SCIENTIFIC OFFICER2024-02-20300$14.72
$4.42kSell
Paul K. AudhyaCHIEF MEDICAL OFFICER2024-02-2014,295$14.12
$201.77kSell
Christopher YeaCHIEF DEVELOPMENT OFFICER2024-02-2012,053$14.12
$170.13kSell
Benjamin L. PalleikoCFO CBO2024-02-2022,802$14.12
$321.85kSell
Thomas Andrew CrockettCEO2024-02-2024,888$14.12
$351.29kSell

1 of 6

KALV insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KALV insiders and whales buy or sell their stock.

KALV Shareholders

What type of owners hold Kalvista Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Vivo Ventures Vi LLC19.68%8,409,126$122.35MInsider
Vr Adviser LLC14.62%6,249,731$90.93MInstitution
Venrock Healthcare Capital Partners Iii LP11.29%4,824,731$70.20MInsider
Interwest Management Partners Ix LLC10.81%4,619,196$67.21MInsider
Acmp Iv LLC10.16%4,343,550$63.20MInsider
Guy P. Nohra10.16%4,343,550$63.20MInsider
Suvretta Capital Management LLC9.81%4,192,005$60.99MInstitution
Tang Capital Management LLC9.65%4,125,345$60.02MInstitution
Frazier Life Sciences Management LP8.63%3,687,867$53.66MInstitution
Albert Cha6.91%2,951,631$42.95MInsider

1 of 3

KALV vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KALV54.12%45.88%Net BuyingNet Selling
ATXS80.71%19.29%Net Buying
PRME39.48%60.52%Net Buying
ARCT88.04%11.96%Net SellingNet Selling
AVBP65.24%31.26%Net Buying

Kalvista Pharmaceuticals Stock Ownership FAQ

Who owns Kalvista Pharmaceuticals?

Kalvista Pharmaceuticals (NASDAQ: KALV) is owned by 109.95% institutional shareholders, 93.20% Kalvista Pharmaceuticals insiders, and 0.00% retail investors. Vivo Ventures Vi LLC is the largest individual Kalvista Pharmaceuticals shareholder, owning 8.41M shares representing 19.68% of the company. Vivo Ventures Vi LLC's Kalvista Pharmaceuticals shares are currently valued at $127.31M.

If you're new to stock investing, here's how to buy Kalvista Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.